Global Diabetic Retinopathy Market Research Report 2023

Report ID: 1974087 | Published Date: Sep 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Diabetic Retinopathy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Laser Surgery
        1.2.3 Injection of Corticosteroids
        1.2.4 Anti-VEGF Drugs
        1.2.5 Vitrectomy
    1.3 Market by Application
        1.3.1 Global Diabetic Retinopathy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Diabetic Retinopathy Market Perspective (2017-2028)
    2.2 Diabetic Retinopathy Growth Trends by Region
        2.2.1 Diabetic Retinopathy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Diabetic Retinopathy Historic Market Size by Region (2017-2022)
        2.2.3 Diabetic Retinopathy Forecasted Market Size by Region (2023-2028)
    2.3 Diabetic Retinopathy Market Dynamics
        2.3.1 Diabetic Retinopathy Industry Trends
        2.3.2 Diabetic Retinopathy Market Drivers
        2.3.3 Diabetic Retinopathy Market Challenges
        2.3.4 Diabetic Retinopathy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Diabetic Retinopathy Players by Revenue
        3.1.1 Global Top Diabetic Retinopathy Players by Revenue (2017-2022)
        3.1.2 Global Diabetic Retinopathy Revenue Market Share by Players (2017-2022)
    3.2 Global Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Diabetic Retinopathy Revenue
    3.4 Global Diabetic Retinopathy Market Concentration Ratio
        3.4.1 Global Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy Revenue in 2021
    3.5 Diabetic Retinopathy Key Players Head office and Area Served
    3.6 Key Players Diabetic Retinopathy Product Solution and Service
    3.7 Date of Enter into Diabetic Retinopathy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Retinopathy Breakdown Data by Type
    4.1 Global Diabetic Retinopathy Historic Market Size by Type (2017-2022)
    4.2 Global Diabetic Retinopathy Forecasted Market Size by Type (2023-2028)
5 Diabetic Retinopathy Breakdown Data by Application
    5.1 Global Diabetic Retinopathy Historic Market Size by Application (2017-2022)
    5.2 Global Diabetic Retinopathy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Diabetic Retinopathy Market Size (2017-2028)
    6.2 North America Diabetic Retinopathy Market Size by Country (2017-2022)
    6.3 North America Diabetic Retinopathy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Diabetic Retinopathy Market Size (2017-2028)
    7.2 Europe Diabetic Retinopathy Market Size by Country (2017-2022)
    7.3 Europe Diabetic Retinopathy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Diabetic Retinopathy Market Size (2017-2028)
    8.2 Asia-Pacific Diabetic Retinopathy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Diabetic Retinopathy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Diabetic Retinopathy Market Size (2017-2028)
    9.2 Latin America Diabetic Retinopathy Market Size by Country (2017-2022)
    9.3 Latin America Diabetic Retinopathy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Diabetic Retinopathy Market Size (2017-2028)
    10.2 Middle East & Africa Diabetic Retinopathy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Diabetic Retinopathy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Detail
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Diabetic Retinopathy Introduction
        11.1.4 Bayer Revenue in Diabetic Retinopathy Business (2017-2022)
        11.1.5 Bayer Recent Development
    11.2 Roche
        11.2.1 Roche Company Detail
        11.2.2 Roche Business Overview
        11.2.3 Roche Diabetic Retinopathy Introduction
        11.2.4 Roche Revenue in Diabetic Retinopathy Business (2017-2022)
        11.2.5 Roche Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Diabetic Retinopathy Introduction
        11.3.4 Novartis Revenue in Diabetic Retinopathy Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 TEVA
        11.4.1 TEVA Company Detail
        11.4.2 TEVA Business Overview
        11.4.3 TEVA Diabetic Retinopathy Introduction
        11.4.4 TEVA Revenue in Diabetic Retinopathy Business (2017-2022)
        11.4.5 TEVA Recent Development
    11.5 Alimera Sciences
        11.5.1 Alimera Sciences Company Detail
        11.5.2 Alimera Sciences Business Overview
        11.5.3 Alimera Sciences Diabetic Retinopathy Introduction
        11.5.4 Alimera Sciences Revenue in Diabetic Retinopathy Business (2017-2022)
        11.5.5 Alimera Sciences Recent Development
    11.6 Regeneron Pharmaceuticals
        11.6.1 Regeneron Pharmaceuticals Company Detail
        11.6.2 Regeneron Pharmaceuticals Business Overview
        11.6.3 Regeneron Pharmaceuticals Diabetic Retinopathy Introduction
        11.6.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2017-2022)
        11.6.5 Regeneron Pharmaceuticals Recent Development
    11.7 Boehringer Ingelheim
        11.7.1 Boehringer Ingelheim Company Detail
        11.7.2 Boehringer Ingelheim Business Overview
        11.7.3 Boehringer Ingelheim Diabetic Retinopathy Introduction
        11.7.4 Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2017-2022)
        11.7.5 Boehringer Ingelheim Recent Development
    11.8 Kowa Group
        11.8.1 Kowa Group Company Detail
        11.8.2 Kowa Group Business Overview
        11.8.3 Kowa Group Diabetic Retinopathy Introduction
        11.8.4 Kowa Group Revenue in Diabetic Retinopathy Business (2017-2022)
        11.8.5 Kowa Group Recent Development
    11.9 Ohr Pharmaceutical
        11.9.1 Ohr Pharmaceutical Company Detail
        11.9.2 Ohr Pharmaceutical Business Overview
        11.9.3 Ohr Pharmaceutical Diabetic Retinopathy Introduction
        11.9.4 Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2017-2022)
        11.9.5 Ohr Pharmaceutical Recent Development
    11.10 Quark Pharmaceuticals
        11.10.1 Quark Pharmaceuticals Company Detail
        11.10.2 Quark Pharmaceuticals Business Overview
        11.10.3 Quark Pharmaceuticals Diabetic Retinopathy Introduction
        11.10.4 Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2017-2022)
        11.10.5 Quark Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Laser Surgery
    Table 3. Key Players of Injection of Corticosteroids
    Table 4. Key Players of Anti-VEGF Drugs
    Table 5. Key Players of Vitrectomy
    Table 6. Global Diabetic Retinopathy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Diabetic Retinopathy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Diabetic Retinopathy Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Diabetic Retinopathy Market Share by Region (2017-2022)
    Table 10. Global Diabetic Retinopathy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Diabetic Retinopathy Market Share by Region (2023-2028)
    Table 12. Diabetic Retinopathy Market Trends
    Table 13. Diabetic Retinopathy Market Drivers
    Table 14. Diabetic Retinopathy Market Challenges
    Table 15. Diabetic Retinopathy Market Restraints
    Table 16. Global Diabetic Retinopathy Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Diabetic Retinopathy Market Share by Players (2017-2022)
    Table 18. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy as of 2021)
    Table 19. Ranking of Global Top Diabetic Retinopathy Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Diabetic Retinopathy Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Diabetic Retinopathy Product Solution and Service
    Table 23. Date of Enter into Diabetic Retinopathy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Diabetic Retinopathy Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Diabetic Retinopathy Revenue Market Share by Type (2017-2022)
    Table 27. Global Diabetic Retinopathy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Diabetic Retinopathy Revenue Market Share by Type (2023-2028)
    Table 29. Global Diabetic Retinopathy Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Diabetic Retinopathy Revenue Market Share by Application (2017-2022)
    Table 31. Global Diabetic Retinopathy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Diabetic Retinopathy Revenue Market Share by Application (2023-2028)
    Table 33. North America Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Diabetic Retinopathy Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Diabetic Retinopathy Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Bayer Company Detail
    Table 44. Bayer Business Overview
    Table 45. Bayer Diabetic Retinopathy Product
    Table 46. Bayer Revenue in Diabetic Retinopathy Business (2017-2022) & (US$ Million)
    Table 47. Bayer Recent Development
    Table 48. Roche Company Detail
    Table 49. Roche Business Overview
    Table 50. Roche Diabetic Retinopathy Product
    Table 51. Roche Revenue in Diabetic Retinopathy Business (2017-2022) & (US$ Million)
    Table 52. Roche Recent Development
    Table 53. Novartis Company Detail
    Table 54. Novartis Business Overview
    Table 55. Novartis Diabetic Retinopathy Product
    Table 56. Novartis Revenue in Diabetic Retinopathy Business (2017-2022) & (US$ Million)
    Table 57. Novartis Recent Development
    Table 58. TEVA Company Detail
    Table 59. TEVA Business Overview
    Table 60. TEVA Diabetic Retinopathy Product
    Table 61. TEVA Revenue in Diabetic Retinopathy Business (2017-2022) & (US$ Million)
    Table 62. TEVA Recent Development
    Table 63. Alimera Sciences Company Detail
    Table 64. Alimera Sciences Business Overview
    Table 65. Alimera Sciences Diabetic Retinopathy Product
    Table 66. Alimera Sciences Revenue in Diabetic Retinopathy Business (2017-2022) & (US$ Million)
    Table 67. Alimera Sciences Recent Development
    Table 68. Regeneron Pharmaceuticals Company Detail
    Table 69. Regeneron Pharmaceuticals Business Overview
    Table 70. Regeneron Pharmaceuticals Diabetic Retinopathy Product
    Table 71. Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2017-2022) & (US$ Million)
    Table 72. Regeneron Pharmaceuticals Recent Development
    Table 73. Boehringer Ingelheim Company Detail
    Table 74. Boehringer Ingelheim Business Overview
    Table 75. Boehringer Ingelheim Diabetic Retinopathy Product
    Table 76. Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2017-2022) & (US$ Million)
    Table 77. Boehringer Ingelheim Recent Development
    Table 78. Kowa Group Company Detail
    Table 79. Kowa Group Business Overview
    Table 80. Kowa Group Diabetic Retinopathy Product
    Table 81. Kowa Group Revenue in Diabetic Retinopathy Business (2017-2022) & (US$ Million)
    Table 82. Kowa Group Recent Development
    Table 83. Ohr Pharmaceutical Company Detail
    Table 84. Ohr Pharmaceutical Business Overview
    Table 85. Ohr Pharmaceutical Diabetic Retinopathy Product
    Table 86. Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2017-2022) & (US$ Million)
    Table 87. Ohr Pharmaceutical Recent Development
    Table 88. Quark Pharmaceuticals Company Detail
    Table 89. Quark Pharmaceuticals Business Overview
    Table 90. Quark Pharmaceuticals Diabetic Retinopathy Product
    Table 91. Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2017-2022) & (US$ Million)
    Table 92. Quark Pharmaceuticals Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diabetic Retinopathy Market Share by Type: 2021 VS 2028
    Figure 2. Laser Surgery Features
    Figure 3. Injection of Corticosteroids Features
    Figure 4. Anti-VEGF Drugs Features
    Figure 5. Vitrectomy Features
    Figure 6. Global Diabetic Retinopathy Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Diabetic Retinopathy Report Years Considered
    Figure 11. Global Diabetic Retinopathy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Diabetic Retinopathy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Diabetic Retinopathy Market Share by Region: 2021 VS 2028
    Figure 14. Global Diabetic Retinopathy Market Share by Players in 2021
    Figure 15. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Diabetic Retinopathy Revenue in 2021
    Figure 17. North America Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Diabetic Retinopathy Market Share by Country (2017-2028)
    Figure 19. United States Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Diabetic Retinopathy Market Share by Country (2017-2028)
    Figure 23. Germany Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Diabetic Retinopathy Market Share by Region (2017-2028)
    Figure 31. China Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Diabetic Retinopathy Market Share by Country (2017-2028)
    Figure 39. Mexico Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Diabetic Retinopathy Market Share by Country (2017-2028)
    Figure 43. Turkey Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Bayer Revenue Growth Rate in Diabetic Retinopathy Business (2017-2022)
    Figure 46. Roche Revenue Growth Rate in Diabetic Retinopathy Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in Diabetic Retinopathy Business (2017-2022)
    Figure 48. TEVA Revenue Growth Rate in Diabetic Retinopathy Business (2017-2022)
    Figure 49. Alimera Sciences Revenue Growth Rate in Diabetic Retinopathy Business (2017-2022)
    Figure 50. Regeneron Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2017-2022)
    Figure 51. Boehringer Ingelheim Revenue Growth Rate in Diabetic Retinopathy Business (2017-2022)
    Figure 52. Kowa Group Revenue Growth Rate in Diabetic Retinopathy Business (2017-2022)
    Figure 53. Ohr Pharmaceutical Revenue Growth Rate in Diabetic Retinopathy Business (2017-2022)
    Figure 54. Quark Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Roche
Novartis
TEVA
Alimera Sciences
Regeneron Pharmaceuticals
Boehringer Ingelheim
Kowa Group
Ohr Pharmaceutical
Quark Pharmaceuticals
Frequently Asked Questions
Diabetic Retinopathy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diabetic Retinopathy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diabetic Retinopathy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports